Dunedin, New Zealand

Carla Joy Meledandri

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Otago Innovation Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carla Joy Meledandri. Retrieved from https://idiyas.com/inventor/carla-joy-meledandri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carla Joy Meledandri: Innovator in Antibacterial Solutions

Introduction

Carla Joy Meledandri is a notable inventor based in Dunedin, New Zealand. She has made significant contributions to the field of antibacterial agents through her innovative research and development. Her work focuses on the assembly of micelle aggregates that incorporate surfactant micelles and silver nanoparticles.

Latest Patents

Carla holds a patent for her invention titled "Assembly of micelle aggregates of surfactant micelles and silver nanoparticles and use as antibacterial agent." This patent describes an assembly of micelle aggregates, wherein each aggregate comprises micelles of an anionic surfactant and nano-sized particles of metallic silver. The product developed from this invention is intended for use in treating or preventing bacterial infections.

Career Highlights

Carla is associated with Otago Innovation Limited, where she continues to advance her research in antibacterial solutions. Her work has garnered attention for its potential applications in healthcare and infection control.

Collaborations

Carla collaborates with Donald Royden Schwass, contributing to the innovative environment at Otago Innovation Limited.

Conclusion

Carla Joy Meledandri's contributions to antibacterial research highlight her role as a leading inventor in her field. Her innovative patent demonstrates the potential for new solutions in combating bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…